Moderna shares rise 6% after the FDA reversed its decision not to review the flu vaccine
Following an earlier surge in pre-market trading, Moderna shares increased 6.4% to approximately $46.75 shortly after the market started on...
Following an earlier surge in pre-market trading, Moderna shares increased 6.4% to approximately $46.75 shortly after the market started on...
Eli Lilly dropped the cost of Zepbound on Monday after the pharmaceutical giant and Ozempic producer Novo Nordisk reached an...
Following President Donald Trump's announcement of a deal with pharmaceutical companies to lower the cost of two well-known medications in...
OpenAI is considering developing consumer health products, including a personal health assistant powered by generative AI, as the creator of...
Nearly a month after departing from her role as CEO of social media platform X, Linda Yaccarino is set to...
The company announced to Forbes on Thursday that Juul will be granted approval from the Food and Drug Administration (FDA)...
In a deal that could be worth over 11 billion dollars for the German company, Bristol Myers Squibb announced Monday...
As Kennedy, a known vaccine skeptic, and other health officials pushed for new federal guidelines in recent weeks, Health and...
The first blood test used to diagnose Alzheimer's disease was cleared by the Food and Drug Administration for marketing on...
Walgreens has agreed to pay $300 million to resolve accusations by US authorities that it fraudulently filled millions of invalid...